Cdc42 is a substrate for caspases and influences Fas-induced apoptosis - PubMed (original) (raw)
. 2001 Jun 1;276(22):19656-63.
doi: 10.1074/jbc.M009838200. Epub 2001 Mar 13.
Affiliations
- PMID: 11278572
- DOI: 10.1074/jbc.M009838200
Free article
Cdc42 is a substrate for caspases and influences Fas-induced apoptosis
S Tu et al. J Biol Chem. 2001.
Free article
Abstract
Fas-mediated apoptosis results in the activation of caspases, which subsequently cleave cellular substrates that are essential for normal cell viability. In the present study, we show that the Ras-related GTP-binding protein Cdc42 is susceptible to caspase-catalyzed proteolysis in a number of cell lines, including NIH3T3 fibroblasts, human breast cancer cells (e.g. T47D), and COS-7 cells. Both caspase-3 and caspase-7 were able to catalyze the cleavage of Cdc42, whereas caspase-6 and caspase-8 were without effect. The susceptibility to the caspase-stimulated degradation is specific; although Rac can also serve as a caspase substrate, neither Rho nor Ras is degraded. Caspase sensitivity is conferred by a consensus sequence (DXXD) that lies immediately upstream of the Rho insert regions (residues 122-134) of Cdc42 and Rac. The removal of a stretch of residues (120) that includes the insert region or site-directed mutagenesis of either aspartic acid 118 or 121 within a constitutively active background (i.e. Cdc42(F28L)) as well as a wild-type Cdc42 background yields Cdc42 molecules that provide a marked protection against Fas ligand-induced apoptosis. Overall, these results are consistent with a model in which Cdc42 acts downstream of Fas, perhaps to influence the rate of apoptosis, with the ultimate caspase-mediated degradation of Cdc42 then allowing for a maximal apoptotic response.
Similar articles
- Antiapoptotic Cdc42 mutants are potent activators of cellular transformation.
Tu SS, Wu WJ, Yang W, Nolbant P, Hahn K, Cerione RA. Tu SS, et al. Biochemistry. 2002 Oct 15;41(41):12350-8. doi: 10.1021/bi026167h. Biochemistry. 2002. PMID: 12369824 - Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL, Elferink C, Novak RF. Starcevic SL, et al. J Natl Cancer Inst. 2001 May 16;93(10):776-82. doi: 10.1093/jnci/93.10.776. J Natl Cancer Inst. 2001. PMID: 11353788 - Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells.
Liu JJ, Nilsson A, Oredsson S, Badmaev V, Zhao WZ, Duan RD. Liu JJ, et al. Carcinogenesis. 2002 Dec;23(12):2087-93. doi: 10.1093/carcin/23.12.2087. Carcinogenesis. 2002. PMID: 12507932 - Human caspases: activation, specificity, and regulation.
Pop C, Salvesen GS. Pop C, et al. J Biol Chem. 2009 Aug 14;284(33):21777-21781. doi: 10.1074/jbc.R800084200. Epub 2009 May 26. J Biol Chem. 2009. PMID: 19473994 Free PMC article. Review. - Caspases and cancer.
Olsson M, Zhivotovsky B. Olsson M, et al. Cell Death Differ. 2011 Sep;18(9):1441-9. doi: 10.1038/cdd.2011.30. Epub 2011 Apr 1. Cell Death Differ. 2011. PMID: 21455218 Free PMC article. Review.
Cited by
- Changes of Ex Vivo Cervical Epithelial Cells Due to Electroporation with JMY.
Halász H, Szatmári Z, Kovács K, Koppán M, Papp S, Szabó-Meleg E, Szatmári D. Halász H, et al. Int J Mol Sci. 2023 Nov 28;24(23):16863. doi: 10.3390/ijms242316863. Int J Mol Sci. 2023. PMID: 38069185 Free PMC article. - p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity.
Guo P, Liu Y, Feng J, Tang S, Wei F, Feng J. Guo P, et al. Arch Toxicol. 2022 Dec;96(12):3143-3162. doi: 10.1007/s00204-022-03384-1. Epub 2022 Sep 18. Arch Toxicol. 2022. PMID: 36116095 Review. - Cholinergic anti-inflammatory pathway ameliorates murine experimental Th2-type colitis by suppressing the migration of plasmacytoid dendritic cells.
Kanauchi Y, Yamamoto T, Yoshida M, Zhang Y, Lee J, Hayashi S, Kadowaki M. Kanauchi Y, et al. Sci Rep. 2022 Jan 7;12(1):54. doi: 10.1038/s41598-021-04154-2. Sci Rep. 2022. PMID: 34997096 Free PMC article. - The ubiquitin ligase RNF8 regulates Rho GTPases and promotes cytoskeletal changes and motility in triple-negative breast cancer cells.
Pereira De Carvalho B, Chern YJ, He J, Chan CH. Pereira De Carvalho B, et al. FEBS Lett. 2021 Jan;595(2):241-252. doi: 10.1002/1873-3468.13999. Epub 2020 Dec 5. FEBS Lett. 2021. PMID: 33205415 Free PMC article. - Knockdown of Tousled‑like kinase 1 inhibits survival of glioblastoma multiforme cells.
Ibrahim K, Abdul Murad NA, Harun R, Jamal R. Ibrahim K, et al. Int J Mol Med. 2020 Aug;46(2):685-699. doi: 10.3892/ijmm.2020.4619. Epub 2020 May 28. Int J Mol Med. 2020. PMID: 32468002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous